FDA Drug Application (018115) for TRIAMINIC-12 by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number018115
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage12MG;75MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRIAMINIC-12
Active IngredientCHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CHLORPHENIRAMINE MALEATE23
List of drugs with Active Ingredient PHENYLPROPANOLAMINE HYDROCHLORIDE4


Back to FDA Applications sponsored by NOVARTIS